Spiral Therapeutics Announces Successful Completion of the SPT-2101 PHASE 1b/2a Clinical Trial for Meniere's Disease, Data Presented During the 2024 AAO Annual Meeting

PR NewswireSep 30 08:44 ET

Otonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.com

Defense WorldMay 1, 2023 01:23 ET

Otonomy (NASDAQ:OTIC) Earns Hold Rating From Analysts at StockNews.com

Financial News LiveApr 2, 2023 04:42 ET

Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board

PR NewswireMar 29, 2023 08:57 ET

Olema Pharmaceuticals (NASDAQ:OLMA) and Otonomy (NASDAQ:OTIC) Critical Comparison

Defense WorldMar 13, 2023 01:54 ET

Requisite Capital Management LLC Acquires Shares of 150,000 Otonomy, Inc. (NASDAQ:OTIC)

Financial News LiveMar 12, 2023 13:03 ET